Minimal Residual Disease Testing Market
Minimal Residual Disease Testing Market
Report Includes
- An overview of the global market for minimal residual disease (MRD) testing
- Analyses of global market trends, with data from 2021, 2022, estimates for 2023 and projections of compound annual growth rates (CAGRs) through 2028
- Highlights of the market potential and characterization of MRD market based on technology, application, end-user category, and region
- Information on technologies used to detect the levels of malignancy that remain after cancer treatment such as flow cytometry, PCR and NGS
- Detailed description of specific somatic or germline mutations that serve as precise markers to diagnose cancer during ongoing investigations
- Coverage of major cancers such as leukaemia, lymphoma, and multiple myeloma, and discussion on how MRD level monitoring enables more precise evaluations, thereby identifying the amount of risk or enabling early prevention of future relapse
- Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the market and a relevant patent analysis
- Detailed company profiles of major players in the market